Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness
- Author
- ABRAM, Michael E1 ; HLUHANICH, Rebecca M1 ; SVAROVSKAIA, Evguenia S1 ; MCCOLL, Damian J1 ; WHITE, Kirsten L1 ; MILLER, Michael D1 ; GOODMAN, Derrick D1 ; ANDREATTA, Kristen N1 ; MARGOT, Nicolas A1 ; LINDA YE1 ; NIEDZIELA-MAJKA, Anita1 ; BARNES, Tiffany L1 ; NOVIKOV, Nikolai1 ; XIAOWU CHEN1
[1] Gilead Sciences, Inc., Foster City, California, United States - Source
Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 6, pp 2654-2663, 10 p ; ref : 57 ref
- CODEN
- AACHAX
- ISSN
- 0066-4804
- Scientific domain
- Microbiology, infectious diseases; Pharmacology drugs
- Publisher
- American Society for Microbiology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antirétroviral Antiviral Elvitégravir Fitness Génétique Mutation Primaire Réplication Résistance SIDA Test sensibilité médicamenteuse Virus HIV1 Integrase Immunodéficit Immunopathologie Infection Inhibiteur de l'intégrase Lentivirus Retroviridae Virose Virus immunodéficience humaine Virus
- Keyword (en)
- Antiretroviral agent Antiviral Elvitegravir Fitness Genetics Mutation Primary Replication Resistance AIDS Drug susceptibility test HIV-1 virus Immune deficiency Immunopathology Infection Integrase inhibitor Lentivirus Retroviridae Viral disease Human immunodeficiency virus Virus
- Keyword (es)
- Antiretroviral Antiviral Elvitegravir Adecuación Genética Mutación Primario Replicación Resistencia SIDA Prueba sensibilidad medicamentosa HIV-1 virus Inmunodeficiencia Inmunopatología Infección Inhibidor integrase Lentivirus Retroviridae Virosis Human immunodeficiency virus Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D01 Immunodeficiencies
- Discipline
- Immunopathology Infectious pathology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27423559
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1128/AAC.02568-12 
https://dx.doi.org/10.1128/AAC.02568-12
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1128\/AAC.02568-12\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2654\";s:8:\"\u0000*\u0000epage\";s:4:\"2663\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ABRAM\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:20:\"HLUHANICH, Rebecca M\";i:1;s:23:\"SVAROVSKAIA, Evguenia S\";i:2;s:16:\"MCCOLL, Damian J\";i:3;s:16:\"WHITE, Kirsten L\";i:4;s:17:\"MILLER, Michael D\";i:5;s:18:\"GOODMAN, Derrick D\";i:6;s:20:\"ANDREATTA, Kristen N\";i:7;s:17:\"MARGOT, Nicolas A\";i:8;s:8:\"LINDA YE\";i:9;s:22:\"NIEDZIELA-MAJKA, Anita\";i:10;s:17:\"BARNES, Tiffany L\";i:11;s:16:\"NOVIKOV, Nikolai\";i:12;s:11:\"XIAOWU CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1128\/AAC.02568-12\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2654\";s:8:\"\u0000*\u0000epage\";s:4:\"2663\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ABRAM\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:20:\"HLUHANICH, Rebecca M\";i:1;s:23:\"SVAROVSKAIA, Evguenia S\";i:2;s:16:\"MCCOLL, Damian J\";i:3;s:16:\"WHITE, Kirsten L\";i:4;s:17:\"MILLER, Michael D\";i:5;s:18:\"GOODMAN, Derrick D\";i:6;s:20:\"ANDREATTA, Kristen N\";i:7;s:17:\"MARGOT, Nicolas A\";i:8;s:8:\"LINDA YE\";i:9;s:22:\"NIEDZIELA-MAJKA, Anita\";i:10;s:17:\"BARNES, Tiffany L\";i:11;s:16:\"NOVIKOV, Nikolai\";i:12;s:11:\"XIAOWU CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1128\/AAC.02568-12\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1128\/AAC.02568-12\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2654\";s:8:\"\u0000*\u0000epage\";s:4:\"2663\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ABRAM\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:20:\"HLUHANICH, Rebecca M\";i:1;s:23:\"SVAROVSKAIA, Evguenia S\";i:2;s:16:\"MCCOLL, Damian J\";i:3;s:16:\"WHITE, Kirsten L\";i:4;s:17:\"MILLER, Michael D\";i:5;s:18:\"GOODMAN, Derrick D\";i:6;s:20:\"ANDREATTA, Kristen N\";i:7;s:17:\"MARGOT, Nicolas A\";i:8;s:8:\"LINDA YE\";i:9;s:22:\"NIEDZIELA-MAJKA, Anita\";i:10;s:17:\"BARNES, Tiffany L\";i:11;s:16:\"NOVIKOV, Nikolai\";i:12;s:11:\"XIAOWU CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1128\/AAC.02568-12\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2654\";s:8:\"\u0000*\u0000epage\";s:4:\"2663\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ABRAM\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:20:\"HLUHANICH, Rebecca M\";i:1;s:23:\"SVAROVSKAIA, Evguenia S\";i:2;s:16:\"MCCOLL, Damian J\";i:3;s:16:\"WHITE, Kirsten L\";i:4;s:17:\"MILLER, Michael D\";i:5;s:18:\"GOODMAN, Derrick D\";i:6;s:20:\"ANDREATTA, Kristen N\";i:7;s:17:\"MARGOT, Nicolas A\";i:8;s:8:\"LINDA YE\";i:9;s:22:\"NIEDZIELA-MAJKA, Anita\";i:10;s:17:\"BARNES, Tiffany L\";i:11;s:16:\"NOVIKOV, Nikolai\";i:12;s:11:\"XIAOWU CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1128\/AAC.02568-12\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2654\";s:8:\"\u0000*\u0000epage\";s:4:\"2663\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ABRAM\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:20:\"HLUHANICH, Rebecca M\";i:1;s:23:\"SVAROVSKAIA, Evguenia S\";i:2;s:16:\"MCCOLL, Damian J\";i:3;s:16:\"WHITE, Kirsten L\";i:4;s:17:\"MILLER, Michael D\";i:5;s:18:\"GOODMAN, Derrick D\";i:6;s:20:\"ANDREATTA, Kristen N\";i:7;s:17:\"MARGOT, Nicolas A\";i:8;s:8:\"LINDA YE\";i:9;s:22:\"NIEDZIELA-MAJKA, Anita\";i:10;s:17:\"BARNES, Tiffany L\";i:11;s:16:\"NOVIKOV, Nikolai\";i:12;s:11:\"XIAOWU CHEN\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:134:\"Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
